Skip to content

Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain

Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain - Phase II

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06968689
Enrollment
60
Registered
2025-05-13
Start date
2025-06-01
Completion date
2028-02-29
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Transcranial Alternating Current Stimulation (tACS)

Brief summary

The purpose of this study is to assess thalamocortical (TC) connectivity during tonic pressure pain, to evaluate alpha activity during tonic pressure pain and to determine pressure pain ratings by using Electroencephalography (EEG), Functional Magnetic Resonance Imaging (fMRI), Transcranial Alternating Current Stimulation (tACS), sham and Transcranial random noise stimulation (tRNS)

Interventions

DEVICEtranscranial alternating current stimulation (tACS)

Participants will get a personalized brain stimulation: a 2 milliampere (mA) oscillating current that matches their natural alpha brain wave frequency (8-12 Hz), determined by a quick 3-minute EEG before the session.

DEVICESham

Active sham stimulation with 60- second -tACS will be applied , then ramp down, and be reintroduced in the last 30 seconds to minimize awareness of the experimental condition

Participants will still get stimulation, but at random frequencies between 1 and 200 Hz (instead of targeted alpha waves).

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER
National Institute of Neurological Disorders and Stroke (NINDS)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Meet the MRI / EEG screening criteria * Fluent in English

Exclusion criteria

* Current or history of major medical, neurological, or psychiatric illness based on self-report * History of cardiac, respiratory, or nervous system disease that, in the investigator's judgment, precludes participation in the study because of a heightened potential for adverse outcome (for example: asthma or claustrophobia) * History of head trauma * Pregnant or lactating * Presence of any contraindications to MRI scanning (for example: cardiac pacemaker, metal implants, claustrophobia, pregnancy, cannot lie still in fMRI scanner) * Conditions making study participation difficult (e.g., paralysis, psychoses, or other severe psychological problems as per the judgment of a study investigator during Session 1) * Active substance abuse disorders (based on subject self-report)

Design outcomes

Primary

MeasureTime frame
Change in thalamocortical (TC) connectivity during tonic pressure pain using fMRIpre-stimulation, post-stimulation (about 30 minutes)
Change in alpha activity during tonic pressure pain using EEGpre-stimulation, post-stimulation (about 30 minutes)

Secondary

MeasureTime frameDescription
Change in pain as assessed by the Visual Analog Scale (VAS)pre-stimulation, post-stimulation (about 30 minutes)The VAS is scored from 0 = no pain; 10 = the most intense pain tolerable, higher number indicating more pain

Countries

United States

Contacts

CONTACTWen Li, PhD
Wen.Li.1@uth.tmc.edu(713) 486-2700
CONTACTJada Malveaux
Jada.Malveaux@uth.tmc.edu(713) 486-2700
PRINCIPAL_INVESTIGATORWen Li, PhD

The University of Texas Health Science Center, Houston

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026